Dudediligence.

Biogen Inc

BIIBNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.47BSep ’24$2.45BDec ’24$2.43BMar ’25$2.65BJun ’25$2.53BSep ’25$2.28BDec ’25$2.48BMar ’26$2.74BJun ’26
Net income, by quarter
$388.5MSep ’24$266.7MDec ’24$240.5MMar ’25$634.8MJun ’25$466.5MSep ’25−$48.8MDec ’25$319.5MMar ’26$97.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$10.98B$10.17B$9.84B$9.68B$9.89B
Gross profit$8.87B$7.90B$7.30B$7.37B$7.49B
Operating income$2.84Bnone on filenone on filenone on filenone on file
Net income$1.56B$3.05B$1.16B$1.63B$1.29B
Operating cash flow$3.64B$1.38B$1.55B$2.88B$2.20B
Free cash flow$3.38B$1.14B$1.27B$2.72B$2.05B
Cash$2.26B$3.42B$1.05B$2.38B$3.01B
Debt$7.27B$6.28B$150.0M$1.75B$6.29B
Shares outstanding147.0M144.0M144.9M145.8M146.8M